ArticleFrontiers in pharmacology2019

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease.

Sara Redenšek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.